{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:13:25Z","timestamp":1747178005646,"version":"3.40.5"},"reference-count":21,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/10428194.2021.2015345","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T08:21:55Z","timestamp":1639729315000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["A PET in a time of need: toward early PET-adapted therapy in DLBCL in first relapse"],"prefix":"10.1080","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-2024","authenticated-orcid":false,"given":"Adrian","family":"Minson","sequence":"first","affiliation":[{"name":"Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-159X","authenticated-orcid":false,"given":"Michael","family":"Hofman","sequence":"additional","affiliation":[{"name":"Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia"},{"name":"Department of Medicine, University of Melbourne, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-5966","authenticated-orcid":false,"given":"Michael","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.0198"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-606939"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001367"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12176"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002814"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007939"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"CIT0010","unstructured":"Locke F. Primary analysis of ZUMA-7: a phase 3 randomized trial of axicabtagene ciloleucel (Axi-Cel) versus standard-of-care therapy in patients with relapsed\/refractory large B-cell lymphoma. 63rd ASH Annual Meeting and Exposition; ASH. 2021, December 11\u201314, Atlanta, GA, United States."},{"key":"CIT0011","unstructured":"Bishop M. Tisagenlecleucel vs. standard of care as second-line therapy of primary refractory or relapsed aggressive B-cell non-Hodgkin lymphoma: analysis of the phase III Belinda study. 63rd ASH Annual Meeting and Exposition; ASH. 2021, December 11-14, Atlanta, GA, United States."},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Kamdar M. Lisocabtagene Maraleucel (liso-cel), a CD19-directed Chimeric Antigen Receptor (CAR) T cell therapy, versus standard of care (SOC) with salvage chemotherapy (CT) followed by autologous stem cell transplantation (ASCT) as second-line (2L) treatment in patients (Pts) with relapsed or refractory (R\/R) large B-cell lymphoma (LBCL): results from the randomized phase 3 transform study. 63rd ASH Annual Meeting and Exposition; ASH. 2021, December 11-14, Atlanta, GA, United States.","DOI":"10.1182\/blood-2021-147913"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-3953-z"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.238923"},{"issue":"1","key":"CIT0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.120.242412","volume":"62","author":"Capobianco N","year":"2021","journal-title":"J Nucl Med"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3315-7"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1966786"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1971223"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003001"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.02.008"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001900"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2021.2015345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T11:51:53Z","timestamp":1644580313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2021.2015345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/10428194.2021.2015345"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2021.2015345","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"type":"print","value":"1042-8194"},{"type":"electronic","value":"1029-2403"}],"subject":[],"published":{"date-parts":[[2021,12,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}